Featured Research

from universities, journals, and other organizations

Variants In Three Estrogen-related Genes Linked To Parkinson's Disease In Women

Date:
April 14, 2006
Source:
Mayo Clinic
Summary:
Mayo Clinic researchers have discovered a possible connection between increased risk for Parkinson's disease and variants in three genes that control estrogen production and activity in the body.

Mayo Clinic researchers have discovered a possible connection between increased risk for Parkinson's disease and variants in three genes that control estrogen production and activity in the body.

The findings will be presented Tuesday at the American Academy of Neurology meeting in San Diego.

"We and other investigators have found evidence that estrogen helps protect women from developing Parkinson's," says Walter Rocca, M.D., M.P.H., Mayo Clinic neurologist and epidemiologist, and lead study investigator. "So, a gene variant that would decrease estrogen production or activity would put those women at greater risk for the disease."

The study associated variants in the following three genes with development of Parkinson's: estrogen receptor 1 gene (ESR1); estrogen receptor 2 gene (ESR2); and PR domain-containing protein 2 gene (PRDM2).

"The gene variants are not a defect or a problem in and of themselves -- they are part of human differences, simply differences across people, like being slim, short or blue-eyed," says Dr. Rocca. "These differences make one subgroup of the population more susceptible to a disease like Parkinson's. However, sometimes the genetic variant is a weak risk factor, and the disease only manifests if another risk factor is present, such as a particular diet, physical exercise, taking certain medications or a medical event."

The study was conducted using a database from a previous study of the entire human genome for genes linked to Parkinson's. For the new study, the Mayo Clinic investigators examined several genes for variants in 172 women who had Parkinson's and 229 women who did not have the disease.

Dr. Rocca explains that some genetic variants the study pinpointed for association with Parkinson's are quite common, affecting 10 to 20 percent of the female population. As women are not routinely tested for these gene variations, however, those affected would be unaware, he says.

"If the findings of this study are replicated and confirmed, the hope is to use these variants to predict the risk of disease using a simple blood test," says Dr. Rocca. He explains that the test would be particularly useful for women and their physicians before deciding to conduct an elective ovariectomy, surgical removal of the ovaries, because a combination of estrogen-reducing factors could amplify a woman's risk for Parkinson's.

Other members of the Mayo Clinic research team included: Brandon Grossardt; Mariza de Andrade, Ph.D.; James Bower, M.D.; and Demetrius Maraganore, M.D. The study was financially supported by grants from the National Institutes of Health.



Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Variants In Three Estrogen-related Genes Linked To Parkinson's Disease In Women." ScienceDaily. ScienceDaily, 14 April 2006. <www.sciencedaily.com/releases/2006/04/060414002812.htm>.
Mayo Clinic. (2006, April 14). Variants In Three Estrogen-related Genes Linked To Parkinson's Disease In Women. ScienceDaily. Retrieved April 24, 2014 from www.sciencedaily.com/releases/2006/04/060414002812.htm
Mayo Clinic. "Variants In Three Estrogen-related Genes Linked To Parkinson's Disease In Women." ScienceDaily. www.sciencedaily.com/releases/2006/04/060414002812.htm (accessed April 24, 2014).

Share This



More Health & Medicine News

Thursday, April 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins